Sep 5 |
Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences
|
Aug 29 |
Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry Summit
|
Aug 8 |
Rapport Therapeutics GAAP EPS of -$1.70 misses by $1.02
|
Aug 8 |
Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update
|
Aug 6 |
3 Under-The-Radar Healthcare Stocks to Buy for Outsized Returns
|
Jul 29 |
Rapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on Pain
|
Jul 2 |
Stifel starts Rapport at buy, cites lead drug candidate RAP-219
|
Jun 29 |
No Holiday Break For Tesla, Constellation Brands, Comcast, And Trump Media
|
Jun 12 |
Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
|
Jun 7 |
Rapport Therapeutics starts trading above IPO price
|